All

The purpose of this collection of papers is to showcase and share learning from those who have had experience of these changes including implementing the use of IT solutions and/or IT science to assist and improve clinical outcomes for patients.

The overarching theme for the research topic is impact of COVID-19 pandemic on cancer care.

 

Submitted by Lynne Nakashima, Chair, ISOPP Immunotherapy Task Force

The ISOPP Immunotherapy Task Force has been hard at work since the fall of 2020, developing resources to assist oncology pharmacy practitioners in managing the care of patients on immunotherapy.

 

ISOPP Position Paper on the role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions:

The position paper developed by the Immunotherapy Task Force has been published online ahead of print by JOPP. View the paper on the ISOPP website here.

 

Hot off the press! The revised ISOPP Standards of Practice has been published.

The revised ISOPP Standards of Practice document has been published in the Journal of Oncology Pharmacy Practice and posted to ISOPP’s website.

 

ISOPP is participating in a Cancer Patient Supportive Care Masterclass and addressing Pharmacogenomics today, February, 2022, presented by Alexandre Chan, PharmD, MPH, BCPS, BCOP, FCCP, FISOPP, APh and Todd Knepper, PharmD respectively!

 

The ISOPP 2022 Virtual Symposium is only 5 weeks away! Join us for leading edge education to advance your oncology pharmacy knowledge from wherever you are!

Register now and guarantee your access to this two day program consisting of plenary speakers, a sponsored symposium, hot topic discussions, ISOPP’s Annual General Meeting, and more!

 

In collaboration with the Saudi Oncology Pharmacy Assembly (SOPA), International Society of Pharmacy Practitioners (ISOPP) conducted its first regional hybrid conference in Riyadh, Saudi Arabia. The scientific program was delivered over 3 days from the 18th to the 20th of November, 2021.

 
www.bopa.org.uk

The 24th British Oncology Pharmacy Association (BOPA) annual symposium was held virtually this year, with an exciting and impressive agenda and the opportunity to participate in a variety of sessions, including industry-led satellites, breakout sessions, poster exhibitions, and plenary sessions from top oncology experts. The talks were entirely interactive, as they had been in previous years. During the poster presentations delegates had the opportunity to ask speakers questions and discuss their up-to-date research.

 

(APOPC) 2021 - a summary of three presentations:

Plenary 1: Innovations to transform oncology pharmacy by Harbans Dhillon

Plenary 11: This Plenary was to showcase the main innovations in compounding of hazardous drugs and was well presented by Hisanaga Nomura from Japan and Bo Yu from China.

Hisanaga Nomura's presentation was entitled Handling Hazardous Drugs with Closed System Transfer Devices, while Bo Yu addressed the topic of Pharmacy Automation.

 

Asia Pacific Oncology Pharmacy Congress (APOPC) is a biennial conference targeting oncology pharmacists, pharmacy technicians and other healthcare professionals practicing in oncology from Asian countries.The year 2021 marks the 3rd anniversary of the Asia Pacific Oncology Pharmacy Community (APOPC) as being transformed from the formerly community of practice known as Asia for Safe Handling.